Aimsio Has Officially Incorporated as a U.S. Based Corporation, Expanding Operations Into Houston, Texas to Better Serve Industrial Clients Across the United States
HOUSTON — Aimsio, a leading provider of field-first operations software for heavy industrial companies, is proud to announce its official incorporation as a U.S. based corporation, marking a major milestone in its growth trajectory and expanding its operational footprint in Houston, Texas, United States.
Article content
Founded in 2013, in Calgary, Alberta Canada— Aimsio has been at the forefront of digital transformation in field operations—streamlining dispatch, ticketing, timesheets, and invoicing for companies in construction, energy, utilities, and transportation. This incorporation signifies a strategic evolution as Aimsio continues to scale its presence across North America and attract more U.S.-based enterprise customers, partners, and investors.
Article content
Article content
'This is more than a legal change—it's a defining moment in Aimsio 's journey,' said Ash Esmaeili, CEO of Aimsio Inc. (USA). 'By incorporating in the United States and anchoring operations in Houston, we're positioning ourselves at the heart of the industries we serve. We're now better equipped to partner with industrial leaders across the U.S. to digitize field operations and help them recover revenue lost to inefficiencies.'
Article content
The new Houston operation will serve as a regional hub for business development, customer success, and partner engagement—enhancing Aimsio 's ability to support its growing customer base across Texas and the broader southern U.S.
Article content
As part of its expansion, Aimsio remains committed to building field-first solutions that connect boots-on-the-ground teams with the back office—empowering companies to work smarter, invoice faster, and grow revenue through better operational visibility.
Article content
Article content
Article content
Article content
Article content
Contacts
Article content
Media Contact:
Article content
Marc Reinhart
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
13 minutes ago
- Globe and Mail
3 Scorching-Hot Artificial Intelligence (AI) Stocks That Can Plunge Up to 72%, According to Select Wall Street Analysts
Key Points Artificial intelligence (AI) is a potential $15.7 trillion addressable market by the turn of the decade. Though Wall Street analysts are, collectively, optimistic about AI stocks, not all AI stocks are necessarily worth buying. Three red-hot AI stocks aren't as bulletproof as investors think, with select analysts forecasting downside ranging from 31% to 72% over the next year. 10 stocks we like better than Palantir Technologies › In the mid-1990s, the advent and proliferation of the internet revolutionized corporate America by opening new sales channels and creating connections that hadn't previously existed. Since the internet, investors have been patiently waiting for the next-big-thing technology to provide a true leap forward for corporate America. The arrival of artificial intelligence (AI) looks to be the answer. AI provides a way for empowered software and systems to make split-second decisions without the need for human oversight or intervention. In Sizing the Prize, the analysts at PwC pegged this global game-changing opportunity at $15.7 trillion (with a "t") by 2030. While sentiment on Wall Street and among analysts has been mostly bullish -- as you'd expect with a $15.7 trillion addressable market -- not every AI stock is necessarily worth buying. According to select Wall Street analysts, three of the market's scorching-hot AI stocks could plunge by as much as 72% over the next year. Palantir Technologies: Implied downside of 72% Though graphics processing unit (GPU) titan Nvidia is the face of the AI movement, arguably no company has come closer to dethroning it than AI and machine learning-driven data-mining specialist Palantir Technologies (NASDAQ: PLTR). Shares of Palantir have soared more than 2,100% since 2023 began, equating to an increase in market value of around $320 billion. The primary reason investors have gravitated to Palantir is its sustainable moat. Its Gotham platform, which secures multiyear contracts from the U.S. government and its immediate allies to collect/analyze data and assist with military mission planning and execution, is irreplaceable. Meanwhile, its Foundry platform, which is designed to help businesses make sense of their data in order to streamline their operations, has no large-scale one-for-one replacement. However, this sustainable moat isn't enough to impress longtime bear Rishi Jaluria at RBC Capital Markets. Although Jaluria nearly quadrupled his price target on the company from $11 to $40 earlier this year, a $40 bullseye would represent 72% downside from the $142.10 per share Palantir stock closed at on July 11. Jaluria's main issue with Palantir stock is something I've harped on repeatedly in recent weeks: its valuation. Prior to the dot-com bubble, many of Wall Street's cutting-edge companies topped out at price-to-sales (P/S) ratios of 31 to 43. Palantir ended the previous week at a P/S ratio of almost 114! No megacap stock in history, to my knowledge, has been able to sustain a valuation this aggressive -- even those with well-defined competitive advantages. Even the slightest operating slip-up or negative news from the U.S. government could clobber Palantir stock. Jaluria also cautioned that Foundry takes too tailored of an approach with its clients, which will hamper its ability to scale. The same can also be said for Gotham, which is only available to the U.S. and its immediate allies. In other words, Palantir stock is on shakier ground than its skyrocketing share price implies. Super Micro Computer: Implied downside of 51% Another red-hot AI stock that has the potential to be pummeled over the next 12 months is customizable rack server and storage solutions specialist Super Micro Computer (NASDAQ: SMCI). Shares of Supermicro are up 62% year-to-date (through July 11) and more than 1,100% on a trailing-three-year basis. The reason it's been a magnet for AI bulls is its role as a provider of customizable rack servers for AI-accelerated data centers. Businesses are aggressively spending on data center infrastructure to gain a competitive edge, and Supermicro's reliance on Nvidia's highly popular AI-GPUs in its rack servers has allowed its servers to sell like hotcakes. Following sales growth of 110% in fiscal 2024 (its fiscal year ends on June 30), Wall Street is forecasting 48% sales growth for fiscal 2025 and another 34% the following year. None of these figures have been enough to dazzle analyst Michael Ng of Goldman Sachs, who rates Super Micro Computer a sell and expects its shares will fall to $24, equating to 51% downside from where they ended the previous week. Ng's skepticism derives from a belief that the AI server market is becoming highly competitive, which is leading less differentiation and, ultimately, weaker pricing power. Ng anticipates Supermicro's gross profit margin will decline throughout the decade, even as sales potentially climb. Though not specifically mentioned by Ng, Super Micro Computer must also overcome a loss of trust with the investing community following allegations of wrongdoing last summer. While an independent committee absolved insiders of any wrongdoing and didn't result in any changes to the company's reported financial statements, it challenged investors' trust in the management team and squashed any chance of Supermicro commanding much of a valuation premium. Even though Supermicro's stock may appear cheap at just 17 times forward-year earnings, there are reasons investors are leery about giving its shares too much of a premium. SoundHound AI: Implied downside of 31% Lastly, AI voice recognition and conversational technologies stock SoundHound AI (NASDAQ: SOUN) can plunge over the coming year, based on the prognostication of one Wall Street analyst. Growth has not been an issue for this up-and-coming AI applications company. Sales for the March-ended quarter jumped 151% to $29.1 million from the prior-year period. This speaks to the company's ability to win new clients in the restaurant, automotive, travel and hospitality, and financial service industries, as well as tie these ecosystems together. Despite SoundHound AI decisively pointing its revenue needle in the right direction, Northland Securities analyst Michael Latimore foresees its stock plummeting to $8 over the next 12 months, which works out to a decline of 31%. Whereas the prior two analysts are decisively negative on Palantir and Supermicro, this isn't the case with Latimore and SoundHound AI. Latimore has a hold rating on the company and is excited about the agentic AI opportunities that lie ahead. The reason price targets should be kept in check is that SoundHound AI has a long way to go before it demonstrates to Wall Street that its operating model can generate profits. Excluding adjustments to contingent acquisition liabilities during the March-ended quarter, its adjusted loss actually widened from $20.2 million to $22.3 million, in spite of 151% growth in net sales from the prior-year quarter. SoundHound AI also burned through close to $19.1 million in cash from its operating activities. The company isn't expected to push into the recurring profit column until 2027, at the earliest. SoundHound AI would also be heavily exposed if an AI bubble formed and burst. Every next-big-thing technology for more than three decades has navigated its way through an early stage bubble, and nothing suggests artificial intelligence is going to be the exception to this unwritten rule. If demand for AI applications even remotely slows, SoundHound AI stock, which is valued at 23 times forward-year sales estimates, will feel the pain. Should you invest $1,000 in Palantir Technologies right now? Before you buy stock in Palantir Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Palantir Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,477!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,010,880!* Now, it's worth noting Stock Advisor 's total average return is1,047% — a market-crushing outperformance compared to180%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 14, 2025
Globe and Mail
13 minutes ago
- Globe and Mail
3 Absurdly Cheap Growth Stocks to Load Up On Right Now
Key Points Novo Nordisk, PayPal, and Dell Technologies are modestly priced growth stocks with a lot of potential to rise higher. They all trade at forward price-to-earnings multiples of 17 or less. 10 stocks we like better than Novo Nordisk › Buying stocks that are trading at cheap valuations can set you up for some big gains later on. And it can minimize the risk of a decline if the market starts to struggle. Although many stocks look expensive today, there are three growth stocks which still seem absurdly cheap right now: Novo Nordisk (NYSE: NVO), PayPal (NASDAQ: PYPL), and Dell Technologies (NYSE: DELL). By investing in these companies, you can gain exposure to some top businesses, while also diversifying your portfolio. Here's a closer look at why each of these stocks can be a good long-term investment. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » Novo Nordisk Drugmaker Novo Nordisk is a terrific healthcare company to consider investing in. The market has been bearish on it over the past year, as recent results from clinical trials haven't met expectations; there are also new concerns that tariffs on pharmaceuticals may weigh down Novo Nordisk and similar stocks. But as concerning as these developments may be, they're also short-term in nature. Novo Nordisk has been a growth-focused business for decades, and some solid products in its portfolio, including Wegovy and Ozempic, have enabled it to generate strong results in recent quarters and put it on track for even more growth in the future. Through the first three months of the year, the company grew its sales by 19% and its operating profit by 22%. The company is a big-name player in the market for GLP-1 medications. And if you invest in it today, you can get it for a modest forward price-to-earnings (P/E) multiple of 17. That's based on analyst estimates, but it gives you a good idea of how cheap the stock is -- the average stock in the S&P 500 trades at a forward P/E of 24. With its encouraging growth prospects, Novo Nordisk could be a no-brainer buy at its current valuation. PayPal A fintech company that doesn't seem to get enough love these days is PayPal. There are certainly concerns that growing competition will chip away at its growth, but its payment platform remains a top choice for customers and vendors to rely on. Its share of the global payments market remains at 45%, making it the top option, despite a flurry of other ways to pay. The company also has its own stablecoin, PayPal USD, so it can potentially leverage opportunities in the crypto space. Growth has been underwhelming of late, as sales through the first three months of the year totaled $7.8 billion, an increase of just 1% year over year. However, the economy is contending with rising costs and tariffs, so consumers scaling back on spending may have more to do with that slowdown than anything PayPal is doing. It's far too early to count PayPal out as a top growth stock: There's still a lot of room for it to grow, especially with PayPal USD in the mix, and its Venmo app is rising in popularity as well. At a forward P/E of only 15, this is an even cheaper stock to own than Novo Nordisk. Dell Technologies Computer maker Dell Technologies isn't doing well with the consumer market this year, but sales of servers have been strong, especially as companies invest heavily in artificial intelligence (AI). For its current fiscal year (which ends in January), Dell projects that its AI server sales will top $15 billion, an increase from the $10 billion total in the previous year. Dell is well positioned to take advantage of AI trends both in the business market and in the consumer market, through the sales of AI computers and servers. While sales of AI computers aren't taking off just yet, it may only be a matter of time before an upgrade cycle takes place, especially as consumers look to take advantage of next-gen computing capabilities. In its most recent quarter, which ended on May 2, Dell's revenue rose by a modest 5% to $23.4 billion. But if not for a 19% decline in its consumer segment, those numbers would have been much better. Dell is a trusted computer manufacturer and it's doing well, even if its operations aren't firing on all cylinders. At a forward P/E of less than 14, this is the cheapest stock on this list. With loads of potential in AI and other computing, Dell may be one of the better growth stocks to buy right now. Should you invest $1,000 in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,477!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,010,880!* Now, it's worth noting Stock Advisor 's total average return is1,047% — a market-crushing outperformance compared to180%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 14, 2025 David Jagielski has positions in Novo Nordisk. The Motley Fool has positions in and recommends PayPal. The Motley Fool recommends Novo Nordisk and recommends the following options: long January 2027 $42.50 calls on PayPal and short June 2025 $77.50 calls on PayPal. The Motley Fool has a disclosure policy.
Globe and Mail
38 minutes ago
- Globe and Mail
Want to Generate at Least $1,000 in Passive Income Per Year? Invest $26,000 in This Dividend King Stock.
Key Points Kenvue is spending big to drum up demand for its diversified product portfolio. The company's weak results reflect pressure on consumer spending. The stock is a good value and has a high yield. 10 stocks we like better than Kenvue › The stock market has historically been a highly effective tool for compounding wealth over time. Another way to use the stock market to achieve your financial goals is to generate income from dividend stocks. Sometimes, it can make sense to target a stodgy company with a high yield, rather than allocate all your savings into high-octane growth stocks. Maybe you're simply looking to diversify, or maybe you're focused on generating a specific amount of dividends to help supplement income in retirement. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » In that case, it may interest you to know that investing $26,000 into Kenvue (NYSE: KVUE), a high-yield consumer staples stock, could earn you at least $1,000 in dividend income per year. Here's why Kenvue stands out as a solid dividend stock to buy now. Kenvue has been struggling since its spinoff In August 2023, Johnson & Johnson spun off its consumer health and hygiene brands under a new publicly traded company called Kenvue. The idea was to allow J&J to focus on its pharmaceutical and medical technology segments, which generally have higher growth prospects than the consumer health division. Kenvue has several well-known brands under categories such as: pain relief and fever (Tylenol, Bengay, etc.) allergy and respiratory (Benadryl, Zyrtec, among others) skin and beauty (Neutrogena, Aveeno, Clean & Clear, etc.) oral health brand (Listerine) baby and child-care brands (Johnson's Baby) digestive health (Lactaid) wound care (Band-Aid and Neosporin) Although established, these brands aren't exactly growing sales at a breakneck pace. It's quite the opposite, in fact. Kenvue's net sales and operating margins have been falling as it struggles to offset inflationary costs and consumer-spending pressures. To make up for the sluggish growth, Kenvue's Vue Forward initiative aims to achieve $350 million in annualized savings by 2026. The company has also been spending a considerable amount on advertising and investing in innovation. In its first quarter, Kenvue launched a variety of marketing campaigns for its biggest brands with social media influencers to appeal to Gen Z consumers. The results led to greater penetration in target markets. So far, however, the ad spending, as a whole, hasn't translated to meaningful bottom-line results. All told, the spinoff hasn't been a success, as measured by Kenvue's results and its underperforming stock price. Navigating industry challenges A major challenge for Kenvue has been private-label brands. Consumers looking to reduce spending may turn to them if they perceive the quality of private-label brands are close enough to name-brand Kenvue items. The threat of private label hurts Kenvue's pricing power, which has been a key differentiator in the consumer staples space among companies that have elite portfolios of brands and can justify price hikes and those that don't. Kenvue has been holding up fairly well despite competition from private-label brands. On its May earnings call, the company said that it hasn't been seeing a shift to private label globally. In fact, private-label penetration in its categories is down slightly. Kenvue's global exposure gives it a unique advantage, compared to companies that are more domestically focused. In its recent quarter, about half of net sales came from North America. The global reach allows the company to offset geographic pressures, such as currency-exchange rates or region-specific changes in consumer behavior. It also drives its brand recognition, which is helping the company hold its own against private-label brands. A high-yield stock at a good value Kenvue's results have been disappointing, but the stock is a good value and has a high yield. Its forward price-to-earnings ratio (P/E) is just 18.8 at the time of this writing, and its dividend yield is 3.9%. And because Kenvue was spun off from Johnson & Johnson, it inherited its status as a Dividend King -- which is a company that has paid and raised its dividend for at least 50 consecutive years. Kenvue raised its dividend in July of last year, so another raise could be on the way in the coming weeks. A worthwhile addition to power a passive-income portfolio Kenvue's nearly two-year stint as an independent company has included a fair share of bumps. The stock is down from its post-split initial price and earnings are trending in the wrong direction. At first glance, Kenvue looks like a stock to avoid, rather than to invest in, but there's arguably a lot of potential for patient investors. The company has an excellent line-up of brands across different product categories and at different price points with a global reach. It hasn't done a good job getting the most out of these brands, but it's also been a challenging operating environment for consumer-focused companies. The consumer staples sector, as a whole, has been selling off as investors gravitate toward higher-growth names amid the broader market rebound. This has pushed companies like Kenvue into the bargain bin. In sum, Kenvue is reasonably valued and offers a generous yield for investors seeking passive income. The stock is worth a closer look for investors who believe in the company's brands, but some individuals may want to take a wait-and-see approach to the stock until management's efforts yield better results. Should you invest $1,000 in Kenvue right now? Before you buy stock in Kenvue, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Kenvue wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider whenNetflixmade this list on December 17, 2004... if you invested $1,000 at the time of our recommendation,you'd have $671,477!* Or when Nvidiamade this list on April 15, 2005... if you invested $1,000 at the time of our recommendation,you'd have $1,010,880!* Now, it's worth notingStock Advisor's total average return is1,047% — a market-crushing outperformance compared to180%for the S&P 500. Don't miss out on the latest top 10 list, available when you joinStock Advisor. See the 10 stocks » *Stock Advisor returns as of July 14, 2025 Daniel Foelber has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Kenvue. The Motley Fool recommends Johnson & Johnson and recommends the following options: long January 2026 $13 calls on Kenvue. The Motley Fool has a disclosure policy.
